Shah, N. A., Paul, S., Parveen, S., Bhat, M. H., Ali, I. and Kadla, S. A. (2025) “Therapeutic outcome of saroglitazar, a peroxisome proliferator activated receptor α/γ agonist in diabetic and non-diabetic metabolic dysfunction associated steatotic liver disease”, International Journal of Basic & Clinical Pharmacology, 14(4), pp. 519–525. doi: 10.18203/2319-2003.ijbcp20251836.